Cardiovascular comorbidities and blood pressure control in stroke survivors

Journal of Hypertension

Volumn 27, Issue 5, 2009, Pages 1056-1063

  Kesarwani, Manoj ^a,b   Perez, Alejandro ^a   Lopez, Victor A ^a   Wong, Nathan D ^a   Franklin, Stanley S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Hypertension; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STROKE; SURVIVOR; SYSTOLIC BLOOD PRESSURE;

EID: 67649651739     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832935ce     Document Type: Article

References (36)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
2. World Health Organization. World Health Report 2002. Reducing risks, promoting healthy life. Geneva: WHO; 2002.
3. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996; 313:147.
4. Wong ND, Lopez VA, L'Italien G, Chen R, Kline SEJ, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007; 167:2431-2436.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
6. Grundy SM, Cleeman JI, Daniels SR, Doneto KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood institute Scientific Statement. Circulation 2005; 112:2735-2752.
7. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Survey Laboratory/Medical Technologists Procedures Manual. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003-2004.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
9. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, et al., American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease; a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761-2788.
10. Mancia G, DeBacker G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. ESH-ESC Practice guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1 751-1 762.
11. Shah BV, Barnwell BG, Bieler GS. SUDAN Users' Manual Release 7.5. Cary, North Carolina: Research Triangle Institute; 1997.
12. SAS Procedures Guide version 6.12. 3rd ed. Cary, North Carolina: SAS Institute; 1995.
13. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota through 1989. Stroke 1996; 27:373-380.
14. Howard G, Labarthe DR, Hu J, Yoon S, Howard VJ. Regional differences in African Americans' high risk for stroke: the remarkable burden of stroke for southern African Americans. Ann Epidemiol 2007; 17:689-696.
15. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147:259-268.
16. Kissela B, Schneider A, Kleindorfer D, Khoury J, Mikker R, Alwell K, et al. Stroke is a biracial population: the excess burden of stroke among blacks. Stroke 2004; 35:426-431.
17. Ayala C, Crodt JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002; 33:1197-1201.
18. Di Carlo A, Lamassa M, Baldereschi M, Praucci G, Basile AM, Wolfe CD, et al., European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34:1114-1119.
19. Johansen HL, Wielgosz AT, Nguyen K, Fry RN. Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada. Can J Cardiol 2006; 22:65-71.
20. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298:789-794.
21. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22:312-318.
22. Burchfiel CM, Curb JD, Rodriguez BL, et al. Glucose intolerance and 22-year stroke incidence: the Honolulu Heart Program. Stroke 1994; 25:951-957.
23. Tuomilehto J, Fastenyte D. Diabetes and glucose intolerance as risk factors for stroke. J Cardiovasc Risk 1999; 6:241-249.
24. Touze E, Varenne O, Chatellier G, Peyranrd S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke. A systematic review and meta-analysis. Stroke 2005; 36:2748-2755.
25. Coca A, Messerli FH, Benetos A, Zhou Q, Champion A, Cooper-DeHoff RM, Pepine CJ. Predicting stroke risk in hypertensive patients with coronary artery disease. A report from the INVEST. Stroke 2008; 39:343-348.
26. Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, Elkind MSV. Risk of myocardial Infarction or vascular death after first ischemic stroke. The Northern Manhattan Study. Stroke 2007; 38:1 752-1758.
27. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, et al. Chronic kidney disease is associated with white matter hyperintensity volume. The northern Matthattan Study (NOMAS). Stroke 2007; 38:3121-3126.
28. Perkovic V, Ninomiya T, Arima H, Gallagher M, Jardine M, Cass A, et al. Chronic kidney disease, cardiovascular events, and the effects of perinodopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol 2007; 18:2766-2772.
29. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MMB. Kidney function is related to cerebral small vessel disease. Stroke 2008; 39:55-61.
30. Sutton-Tyrrell K, Venkitachalam L, Kanaya AM, Boudreau R, Harris T, Thompson T, et al., for The Health, Aginf, and Body Composition Study. Relationship of ankle blood pressures to cardiovascular events in older adults. Stroke 2008; 39:863-869.
31. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34:2741-2748.
32. Irie K, Yamaguchi T, Minematsu K, Omae T. The j-curve phenomenon in stroke recurrence. Stroke 1993; 24:1844-1849.
33. PROGRESS collaborative group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358:1033-1041.
34. PROGRESS collaborative group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006; 24:1201-1208.
35. World Health Organization-International Society of Hypertension. World Health Organization-International Society of Hypertension Statement on Blood Pressure Lowering and Stroke Prevention. J Hypertens 2003; 21:651-663.
36. Hankey GJ, Jamrozik K, Broashurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31:2080-2086.